EUVIMEDOpdag EUVIMED
Crossref

Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum

Francesco Ricci, Caterina Motta, Chiara Giuseppina Bonomi, Francesca Bernocchi, Martina Poli, Giacomo Koch, Agostino Chiaravalloti, Alessandro Martorana

Aging · 2026-02-13 · 18 (1) · 1494-1514

DOI: 10.18632/aging.206393 ↗

At a glance

Journal article in Aging, published online on 2026-11-03. Written by Francesco Ricci and 7 co-authors. Institution: Non Invasive Brain Stimulation Unit, IRCCS Santa Lucia, Rome 00179, Italy. Major MEDLINE topics: Alzheimer Disease, Blood-Brain Barrier, Glucose, Brain. 56 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Within the ATN framework of Alzheimer's disease (AD), patients are classified according to the presence of amyloid pathology (A), tau pathology (T), and neurodegeneration (N). While the A⁺T⁺N⁺ profile is well characterized, the A⁺T⁻N⁺ subgroup remains less understood. This phenotype may reflect mechanisms distinct from tau-driven pathology, potentially involving other amyloid co-pathology such as blood-brain barrier (BBB) dysfunction. METHODS: We examined A⁺T⁻N⁺ and A⁺T⁺N⁺ patients within the AD continuum (ADc) and cognitively healthy controls. All participants underwent cerebrospinal fluid (CSF) biomarker assessment and 18F-FDG positron emission tomography (FDG-PET). The CSF/serum albumin quotient (QAlb) was used as an index of BBB integrity. Voxel-wise multiple regression analyses evaluated associations between regional glucose metabolism and CSF biomarkers, QAlb, demographics, cognitive status, ApoE genotype, and vascular risk factors (Hypertension, Diabetes, and Hypercholesterolemia). RESULTS: Both AD subgroups showed hypometabolism in temporoparietal Default Mode Network regions. In ADc and A⁺T⁺N⁺ patients, posterior metabolism correlated positively with p-tau and negatively with t-tau. In A⁺T⁻N⁺ individuals, posterior hypometabolism was negatively associated with QAlb and positively with Aβ₄₂. Only Hypertension correlated with metabolism, involving the anterior cingulate cortex in ADc and A⁺T⁺N⁺, but not A⁺T⁻N⁺. CONCLUSIONS: Within the AD continuum, A⁺T⁻N⁺ represent a subgroup of patients in whom FDG-PET metabolic dysfunctions appear to be associated with the coexistence of BBB dysfunction alongside amyloid pathology rather than tau-driven mechanisms.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseBlood-Brain BarrierGlucoseBrainHumansFemaleAgedMalePositron-Emission Tomographytau ProteinsBiomarkersFluorodeoxyglucose F18Amyloid beta-PeptidesAged, 80 and overCase-Control Studies

Author keywords

AD biomarkersAlzheimer’s disease continuumFDG-PETblood-brain-barrierbrain metabolism

Substances

Glucosetau ProteinsBiomarkersFluorodeoxyglucose F18Amyloid beta-Peptides

Authors and institutions

  • Non Invasive Brain Stimulation Unit, IRCCS Santa Lucia, Rome 00179, Italy.
  • UOSD Centro Demenze, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome 00133, Italy.
  • Human Physiology Unit, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara 44121, Italy.
  • Department of Nuclear Medicine, Policlinico Tor Vergata, University of Rome Tor Vergata, Rome 00133, Italy.
  • IRCCS Neuromed, Pozzilli 86077, Italy.

Cite

APA

Ricci, F., Motta, C., Bonomi, C. G., Bernocchi, F., Poli, M., Koch, G., Chiaravalloti, A., & Martorana, A. (2026). Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum. Aging, 18(1), 1494-1514. https://doi.org/10.18632/aging.206393

Vancouver

Ricci F, Motta C, Bonomi CG, Bernocchi F, Poli M, Koch G, et al. Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum. Aging. 2026;18(1):1494-1514. doi:10.18632/aging.206393

BibTeX
@article{Ricci2026,
  author = {Ricci, Francesco and Motta, Caterina and Bonomi, Chiara Giuseppina and Bernocchi, Francesca and Poli, Martina and Koch, Giacomo and Chiaravalloti, Agostino and Martorana, Alessandro},
  title = {Brain glucose metabolism and blood brain barrier permeability in Alzheimer’s disease continuum},
  journal = {Aging},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {1494--1514},
  doi = {10.18632/aging.206393}
}
Start for free →